With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in ovarian cancer research news. This post rounds-up all that news and puts it in one place for you. All women with ovarian cancer should consider … Continued
Each spring, Congress takes up the task of allocating money to federal programs. And each spring, the Ovarian Cancer National Alliance works to ensure that ovarian cancer research funding remains a top priority. This year was no exception. On Wednesday, 108 Members of the House of Representatives sent a letter to the House Appropriations Committee … Continued
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology (SGO) meeting. Some of the biggest news for the ovarian cancer community is summarized below, including SGO’s recommendations regarding genetic testing of ovarian cancer patients … Continued
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in the treatment of some platinum resistant ovarian cancers. Vynfinit, developed by Endocyte, targets ovarian cancer cells that have abnormally high levels of the folate receptor. … Continued
On March 25 the Supreme Court will hear arguments in two lawsuits that challenge whether for-profit employers must provide health insurance that covers birth control. The lawsuits involve a provision of the Affordable Care Act that requires insurance plans to cover preventive health services, including contraceptives. A number of companies challenged the law, arguing that … Continued
FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because they “cannot control their libidos or their reproductive systems,” the Ovarian Cancer National Alliance issued the following statement from CEO Calaneet Balas: “In his quest for a quotable sound … Continued
The Supreme Court recently announced that it will hear two cases involving insurance coverage for birth control. The Alliance weighed in on one of these cases, arguing that oral contraceptives are a proven way to prevent ovarian cancer and should therefore be made available to women who wish to reduce their risk. Our CEO Calaneet … Continued
Many Americans will begin shopping for health insurance on October 1 through the new insurance marketplaces. As a cancer patient, you have unique health care needs that you may want to consider. The Ovarian Cancer National Alliance has partnered with 18 patient advocacy organizations to launch a new tool that will help you pick the … Continued
“This month, we extend a hand to all women battling ovarian cancer. We pledge our support to them, to their families, and to the goal of defeating this disease.”-President Barack Obama Read full proclamation here.
We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new studies on or related to ovarian cancer were presented at this year’s ASCO meeting. Click here to read a summary of ovarian cancer research from … Continued
Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent the ovarian patient community. Other diseases, including cancer, brain and heart disease are represented as well. … Continued
Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States Court of Appeals for the Federal Circuit in August 2012, which upheld a patent claim on the BRCA1 … Continued
Get email updates about research news, action alerts, and ways to join the fight.
